U.S. FDA Approves Serenity Pharmaceutical’s Noctiva(TM) (desmopressin acetate) – the First Drug Approved for the Treatment of Nocturia

MILFORD, Pa.--(Healthcare Sales &Marketing Network)--Serenity Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) approved Noctiva™ (desmopressin acetate) nasal spray for the treatment of nocturia due to nocturnal polyuria in adults... Biopharmaceuticals, FDA Serenity Pharmaceuticals, Noctiva, desmopressin, nocturia
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news

Related Links:

In this study, we performed molecular dynamics simulations to provide quantitative comprehension of the thin brine film characteristics that wets carbonate reservoir rocks at molecular level. While an electric double layer is formed at the interface of calcite/low salinity water, the ions in the high saline water form several aggregates of ions. We found that these aggregates persist inside the nano-layer brine separating oil film from carbonate surface and act as anchors that hold oil components in the vicinity of the substrate. This phenomenon is suggested to be responsible for oil attachment to the carbonate reservoirs ...
Source: Colloids and Surfaces A: Physicochemical and Engineering Aspects - Category: Chemistry Source Type: research
Conditions:   Sleep Fragmentation;   Poor Quality Sleep;   Nocturia;   Nocturnal Enuresis Interventions:   Behavioral: BBTI;   Behavioral: IC Sponsors:   University of Pittsburgh;   National Institute on Aging (NIA) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
MacromoleculesDOI: 10.1021/acs.macromol.8b02666
Source: Macromolecules - Category: Chemistry Authors: Source Type: research
ACS Applied Materials&InterfacesDOI: 10.1021/acsami.8b22206
Source: ACS Applied Materials and Interfaces - Category: Materials Science Authors: Source Type: research
CONCLUSIONSurgeons should be aware of the persistent renal defects caused by long term lithium use and development of nephrogenic diabetes insipidus even years after medication cessation.
Source: International Journal of Surgery Case Reports - Category: Surgery Source Type: research
CONCLUSIONS: Patients with hemophilia A treated with bypassing agents between 2007 and 2014 incurred substantially higher monthly hemophilia-related medical and pharmacy costs than patients treated only with FVIII replacement. PMID: 30888200 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research
The pathophysiology and genetic influences in nocturnal enuresis have not been fully elucidated. Delayed neuronal maturation has been suggested as a pathogenetic mechanism in primary monosymptomatic nocturnal enuresis (PMNE). Brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) are neurotrophins affecting maturation of the nervous system.
Source: Journal of Pediatric Urology - Category: Urology & Nephrology Authors: Source Type: research
ConclusionsPerampanel is effective against various types of seizures, including ES, in pediatric patients with refractory epilepsy. Furthermore, PER has good tolerability when the dose is adjusted based on serum concentrations. The PER CD ratio was lower in pediatric patients than in adolescents and adults; therefore, clinicians must consider the CD ratio when treating children with PER.
Source: Epilepsy and Behavior - Category: Neurology Source Type: research
In this study, a review of the existing literature on the individualization of dosing based on PK guidance was performed. In total, 79 articles were included. The methods to individualize dosing were divided into 3 categories: (1) methods using clinical parameters, (2) empirical individual PK-guided methods, and (3) maximum a posteriori (MAP) Bayesian estimation methods. The clinical parameter mainly used to individualize dosing is bleeding phenotype. Dosing based on bleeding phenotype may decrease clotting factor consumption. However, with this method, it is not possible to individualize on-demand dosing during bleeding e...
Source: Therapeutic Drug Monitoring - Category: Drugs & Pharmacology Tags: Review Articles: Focus on Pharmacodynamic Drug Monitoring Source Type: research
ConclusionThe pharmacologic profile of chlorobutanol (synergistic IKR block) and its association with reports of TdP and QT prolongation suggest the need for a full evaluation of its cardiac safety when used as a preservative in IV drug and vitamin formulations.
Source: Drug Safety - Category: Drugs & Pharmacology Source Type: research
More News: Bed Wetting | Enuresis | Food and Drug Administration (FDA) | Marketing | Pharmaceuticals